AU3062599A - Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease) - Google Patents

Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease) Download PDF

Info

Publication number
AU3062599A
AU3062599A AU30625/99A AU3062599A AU3062599A AU 3062599 A AU3062599 A AU 3062599A AU 30625/99 A AU30625/99 A AU 30625/99A AU 3062599 A AU3062599 A AU 3062599A AU 3062599 A AU3062599 A AU 3062599A
Authority
AU
Australia
Prior art keywords
glucocorticosteroid
administered
use according
less
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30625/99A
Other languages
English (en)
Inventor
Ralph Brattsand
Stefan Ohlsson
Carl Goran Persson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU3062599A publication Critical patent/AU3062599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU30625/99A 1998-04-20 1999-03-18 Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease) Abandoned AU3062599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9801368 1998-04-20
SE9801368A SE9801368D0 (sv) 1998-04-20 1998-04-20 New use
PCT/SE1999/000426 WO1999053926A1 (en) 1998-04-20 1999-03-18 Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease)

Publications (1)

Publication Number Publication Date
AU3062599A true AU3062599A (en) 1999-11-08

Family

ID=20411015

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30625/99A Abandoned AU3062599A (en) 1998-04-20 1999-03-18 Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease)

Country Status (10)

Country Link
EP (1) EP1073441A1 (zh)
JP (1) JP2002512193A (zh)
CN (1) CN1306429A (zh)
AR (1) AR018191A1 (zh)
AU (1) AU3062599A (zh)
BR (1) BR9909786A (zh)
CA (1) CA2329008A1 (zh)
HK (1) HK1038703A1 (zh)
SE (1) SE9801368D0 (zh)
WO (1) WO1999053926A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9912534D0 (en) 1999-05-29 1999-07-28 Glaxo Group Res Ltd Novel prognostic surrogate
ECSP003747A (es) * 1999-11-02 2002-05-23 Smithkline Beecham Corp Metodo y composiciones para el tratamiento de las enfermedades pulmonares
DK1572217T3 (da) 2002-12-12 2008-12-15 Nycomed Gmbh Kombinationsmedikament af R,R-formoterol og ciclesonid
WO2004070058A1 (en) * 2003-02-03 2004-08-19 Bayer Healthcare Ag Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of copd
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
CA2540005A1 (en) * 2003-09-26 2005-04-07 Schering Corporation Pulmonary disease treatment
JP2007533706A (ja) * 2004-04-20 2007-11-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用

Also Published As

Publication number Publication date
HK1038703A1 (zh) 2002-03-28
CN1306429A (zh) 2001-08-01
CA2329008A1 (en) 1999-10-28
BR9909786A (pt) 2000-12-19
WO1999053926A1 (en) 1999-10-28
JP2002512193A (ja) 2002-04-23
AR018191A1 (es) 2001-10-31
EP1073441A1 (en) 2001-02-07
SE9801368D0 (sv) 1998-04-20

Similar Documents

Publication Publication Date Title
JP5247265B2 (ja) 気道流路および肺疾患の処置のためのモメタゾンフロエートの使用
AU715319B2 (en) New combination
Edsbäcker et al. Do airway clearance mechanisms influence the local and systemic effects of inhaled corticosteroids?
PT1480615E (pt) Formulação superfina de formoterol
JP2002517450A (ja) 喘息の急性状態の予防または処置のための、ホルモテロールおよびブデソニドを含んでなる組成物の使用
AU2015261103A1 (en) Combinations of tiotropium bromide, formoterol and budesonide for the treatment of COPD
WO2000053187A1 (en) New combination of formoterol and mometasone in a pharmaceutical composition for treating respiratory disorders, such as asthma, rhinitis and copd
AU3062599A (en) Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease)
CN107050024A (zh) 用于改善呼吸系统疾病患者睡眠质量的阿地铵
US20140342001A1 (en) Medicaments
US20040101482A1 (en) Medicaments
WO2000053188A1 (en) New combination of r,r-formoterol and budesonide in a pharmaceutical composition useful for treating respiratory disorders, such as asthma, rhinitis and copd
WO1999000134A1 (en) New combination of antiasthma medicaments
CA2563556C (en) Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
US20080107609A1 (en) Pulmonary disease treatment
MXPA00009981A (en) Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease)
Escribano et al. Clinical comparability between the CFC and HFA budesonide pressurised metered-dose inhalers in paediatric patients with asthma: a randomised controlled trial
Chambers et al. Beclomethasone dipropionate aerosol in the treatment of asthma in steroid-independent children
CZ20003874A3 (cs) Použití glukokortikosteroidu k výrobě léčiva pro léčbu mírných/počátečních forem chronické obstrukční plicní choroby
Nuraliyeva et al. USE OF ANTILEUKOTRIENE DRUGS IN PEDIATRICS

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted